BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10620554)

  • 1. Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath.
    Schenk P; Rosenkranz AR; Wölfl G; Hörl WH; Traindl O
    Am J Kidney Dis; 2000 Jan; 35(1):130-6. PubMed ID: 10620554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparison of two types of tunneled hemodialysis catheters: the Ash Split versus the PermCath.
    O'Dwyer H; Fotheringham T; O'Kelly P; Doyle S; Haslam P; McGrath F; Conlon P; Lee MJ
    Cardiovasc Intervent Radiol; 2005; 28(1):23-9. PubMed ID: 15602643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator as a hemodialysis catheter locking solution.
    McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
    Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood recirculation in temporary central catheters for acute hemodialysis.
    Leblanc M; Fedak S; Mokris G; Paganini EP
    Clin Nephrol; 1996 May; 45(5):315-9. PubMed ID: 8738663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of permanent double lumen catheters in hemodialysis patients.
    Dunea G; Domenico L; Gunnerson P; Winston-Willis F
    ASAIO Trans; 1991; 37(3):M276-7. PubMed ID: 1751147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator (t-PA) efficacy in the restoration of hemodialysis catheter function.
    Meers C; Toffelmire EB
    CANNT J; 1999; 9(4):25-8. PubMed ID: 15714785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequacy of haemodialysis with cuffed central-vein catheters.
    Atherikul K; Schwab SJ; Conlon PJ
    Nephrol Dial Transplant; 1998 Mar; 13(3):745-9. PubMed ID: 9550658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do AshSplit haemodialysis catheters provide better flow rates in the long term?
    Keeling AN; O'Dwyer H; Lyon S; O'Kelly P; McGrath FP; Conlon PJ; Lee MJ
    Ren Fail; 2007; 29(6):721-9. PubMed ID: 17763168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emergency vascular access in patients with renal failure. Apropos of 32 implantations of permcath].
    Chatelard P; Trolliet P; Gilly F; Devolfe C; Caillot JL; Chazot C; François B; Bouchet A
    J Chir (Paris); 1990 Jan; 127(1):13-6. PubMed ID: 2312626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
    García Cortés MJ; Viedma G; Sánchez Perales MC; Borrego FJ; Borrego J; Pérez del Barrio P; Gil Cunquero JM; Liébana A; Pérez Bañasco V
    Nefrologia; 2005; 25(3):307-14. PubMed ID: 16053012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All currently used measurements of recirculation in blood access by chemical methods are flawed due to intradialytic disequilibrium or recirculation at low flow.
    Twardowski ZJ; Van Stone JC; Haynie JD
    Am J Kidney Dis; 1998 Dec; 32(6):1046-58. PubMed ID: 9856523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with the double lumen Silastic catheter for hemoaccess.
    Bour ES; Weaver AS; Yang HC; Gifford RR
    Surg Gynecol Obstet; 1990 Jul; 171(1):33-9. PubMed ID: 2163116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK; Panhotra BR
    J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic and acute consequences of a post-dialysis urokinase lock on permanent hemodialysis catheter function.
    Gabutti L; Mosconi E; Pellegrini L; Duchini F; Marone C
    J Nephrol; 2006; 19(2):183-8. PubMed ID: 16736417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central venous dialysis catheter. Silicone rubber dialysis catheter used for permanent vascular access].
    Paulsen D; Aasen M; Fauchald P; Jakobsen A; Lien BH; Onstad A
    Tidsskr Nor Laegeforen; 1992 Apr; 112(10):1304-5. PubMed ID: 1579915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
    Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
    Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
    ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoral vein tunneled catheters as a last resort to vascular access: report of five cases and review of literature.
    Budruddin M; Mohsin N; Amitabh J; Ehab M; Pramod K; Abbas P; Khalil M; Al-Lawati S
    Ren Fail; 2009; 31(4):320-2. PubMed ID: 19462282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.